key: cord-0837110-0lh7z074 authors: Lim, Michael Anthonius; Kurniawan, Antonius Andi title: Dreadful Consequences of Sarcopenia and Osteoporosis due to COVID-19 Containment date: 2021-02-10 journal: Geriatr Orthop Surg Rehabil DOI: 10.1177/2151459321992746 sha: 728bc39bfd1b2552e032b65a022d3dcb76ae1165 doc_id: 837110 cord_uid: 0lh7z074 nan The alteration in lifestyle behavior due to COVID-19 containment measures result in the imbalance in muscle-bone unit synthesis and breakdown, leading to acute changes in body composition described as osteosarcopenic obesity. This unfavorable state promotes more oxidative stress and proinflammatory cytokines, exacerbating muscle dysfunction, impaired locomotion, bone deterioration, and increased long-term health risks as well as COVID-19 risk. 1 Bone loss was faster in osteosarcopenic compared to individuals with osteopenia or sarcopenia only. 13 The odds ratio of fracture was over 2 to 3 times higher in osteosarcopenic compared to those with normal BMD or normal muscle mass. 14,15 Also, the relative risk of fracture is higher among individuals with sarcopenia. 12 In the age of COVID-19, musculoskeletal injury is on the lower list of clinical priorities, with many healthcare providers deferring or minimizing elective orthopedic services to make room for COVID-19 patients. Unfortunately, delays in managing emergency trauma or fracture cases, including seeking alternative or traditional treatments, can lead to catastrophic events such as osteomyelitis, soft tissue infection, compartment syndrome, delayed union, malunion, and nonunion. 16 This has broad implications for the care of patients with bone fragility, with more efforts should be deployed to prevent fragility fractures. Otherwise, a surge in fracture incidence and associated morbidity and mortality is expected in the near future. 17 During the COVID-19 period, the proportion of low-energy fall increased over 2 times compared to the pre-pandemic. This injury mostly found in the elderly, resulting in fragility fractures. Home-confinement contributed to a rise in the proportion of injuries that occur at home, which was almost 4 times higher during the current outbreak. 18 Although the incidence of major traumas has decreased markedly since the start of COVID-19 outbreak, the rate of fragility hip fracture remains unaffected. 19 Osteoporosis, which is a highly preventable and treatable condition, is on the rise globally and it has a profound impact on the physical, psychological, as well as the financial status of individuals and their caregivers. 17 Osteoporotic hip fracture remains a leading cause of morbidity and mortality in the older population where this condition often causes functional disability with a 1-year mortality of 20%. 20 Concomitant COVID-19 infection substantially increased the risk of mortality in patients with hip fracture to around 36%. 21 This raises great concerns among the geriatric population, since they were among individuals at high-risk of contracting COVID-19 or experiencing osteoporotic fractures. Besides, it has been found that the 30-day mortality of fracture patients during the pandemic was up to 2 times higher than that observed in the pre-pandemic situation. 18 The prevalence of sarcopenia was 37% among previously ambulatory, community-based hip fracture patients. Other than the DEXA scan, the use of anthropometry, grip strength, and self-reported mobility could be an alternative option for determining sarcopenia in postoperative hip fracture patients. 22 However, these assessments did not predict the change in mobility in the year after hip fracture. 23 Even though sarcopenia did not affect the 1-year mortality rate of patients with osteoporotic hip fracture, it significantly increased the risk of 5-year mortality. Both perioperative sarcopenia and osteoporosis affected the 5-year mortality rate. 24 An osteoporotic fracture occurs in 1 in 3 men and 1 in 5 women throughout their lifetime with an estimated 5.8 million disability-adjusted life years (DALYs) are lost every year. 25 The risk of recurrent fracture and fracture-associated complications is greatest in the next 12 months after the initial osteoporotic fracture. Therefore, timely assessment and management to prevent further fracture are imperative. A multidisciplinary approach is recommended to guarantee not only adequate surgical treatment but also appropriate care after discharge through a Fracture Liaison Service (FLS). Under normal circumstances, clinical management of patients with suspected osteoporosis or fragility fractures is already complex and neglected. Since the beginning of the outbreak, routine bone density assessments, such as DEXA scan, are no longer feasible given the extensive restrictions related to COVID-19 and limitations on in-person medical appointment. This eventually increases reliance on the use of fracture risk calculators alone, such as Fracture Risk Assessment Tool (FRAX). 17, 20 Older people tend to have at least 1 comorbidity, which results in chronic, low-grade, systemic inflammation and increases the likelihood of experiencing cytokine storm when contracting COVID-19. 10, 26, 27 Sedentariness and/or immobilization accelerates the loss of muscle mass and strength as well as depletion of bone density, which contribute to an increased risk of falls as well as COVID-19-related complications. 2, 21 Frailty worsens the physical and mental health status which hinders the recovery and return to the independence of performing activities of daily living (ADLs) if it is ever achieved. 4 Furthermore, long-term glucocorticoid treatment increases the risk of fragility fracture and leads to steroid dependency. 28 The continuity of care is not only a prerequisite for successful treatment but also crucial for maintaining patient safety for a particular treatment, such as bisphosphonates and denosumab. Joint guidance on osteoporosis management in the COVID-19 era have been introduced by a multi-stakeholder and international coalition convened by the American Society for Bone and Mineral Research (ASBMR). 29 The use of telehealth appointment instead of traditional visit is strongly advised to preserve the continuity of care, including access to rehabilitation while minimizing the risk of nosocomial transmission. This online-based, audiovisual guided session proved to be a cost-effective option and was not inferior to the conventional face-to-face appointment. 30, 31 However, weighing the risks and benefits of escalating or alternating treatment will be challenging in the current climate. 20 Patients with sarcopenia and bone fragility are encouraged to practice a physically active lifestyle, complemented with proper diet and nutrition as well as good sleep quality and stress management. 1 A multicomponent exercise, including aerobic, resistance, balance, and coordination training is advised to enhance their strength, balance, posture, gait, and ultimately reduce the risk of falls. These home-based exercise programs, under the supervision of medical expertise, are proven to be feasible and effective in improving the quality of life of the elderly. 32 Regular exercise, when practiced in moderation, is associated with better physical and psychological well-being, a boost in the immune system, and a lower risk of opportunistic infections. 33 A balanced diet consisting of sufficient amounts of proteins, calcium, and various micronutrients should not be underestimated. 11 Also, vitamin D supplementation should be recommended given the beneficial effects not only on the skeleton but also on muscle function, gait, and immunity in patients with COVID-19. 17, 34 During and after the COVID-19 crisis, more attention should be directed to the care of people with osteoporosis and sarcopenia, especially the susceptible elderly, to avoid a spike in fracture cases and a wave of non-communicable diseases in the coming years. 3 Healthcare workers are already overwhelmed by the increasing number of new COVID-19 cases, which pose a serious economic burden to the community. While mitigation approaches must be increasingly enforced to limit the spread of infection, prevention strategies through the practice of a physically active lifestyle and healthy, quality diet and appropriate management with continuity of care are considered to be substantial correctable factors in lowering morbidity and mortality associated with fragility fractures and chronic conditions. 1 Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss The danger of sedentary lifestyle in diabetic and obese people during the COVID-19 pandemic A wave of noncommunicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia-a systematic review, meta-analysis, and meta-regression: diabetes and COVID-19 Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis Osteoporosis and sarcopenia: two diseases or one? Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis Osteosarcopenia is more than sarcopenia and osteopenia alone Phenotype of osteosarcopenia in older individuals with a history of falling Low lean mass predicts incident fractures independently from FRAX: a prospective cohort study of recent retirees Impending catastrophe of delayed fracture management during the COVID-19 pandemic Managing fragility fractures during the COVID-19 pandemic Epidemiological pattern of orthopaedic fracture during the COVID-19 pandemic: a systematic review and meta-analysis Where did all the trauma go? A rapid review of the demands on orthopaedic services at a UK Major Trauma Centre during the COVID-19 pandemic Osteoporosis in the age of COVID-19 Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture-a systematic review and meta-analysis Sarcopenia in patients with hip fracture: a multicenter cross-sectional study Does sarcopenia predict change in mobility after hip fracture? A multicenter observational study with one-year follow-up Effect of sarcopenia on postoperative mortality in osteoporotic hip fracture patients Clinical practice. Postmenopausal osteoporosis Creactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis Elevated interleukin levels are associated with higher severity and mortality in COVID 19-a systematic review, meta-analysis, and meta-regression Worrying situation regarding the use of dexamethasone for COVID-19 Osteoporosis management in the era of COVID-19 Teleorthopedic: a promising option during and after the coronavirus disease 2019 (COVID-19) pandemic. Front Surg Letter to the editor regarding 'The challenging battle of mankind against COVID-19 outbreak: Is this global international biological catastrophe the beginning of a new era? '-Is telehealth the future of orthopaedic and rehabilitation in post-COVID-19 era Sports activities during any pandemic lockdown Exercise addiction and COVID-19-associated restrictions COVID-19 and misinformation: how an infodemic fueled the prominence of vitamin D